Ofloxacina Viatris

Ofloxacin, the active ingredient in Ofloxacina Viatris, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional. Ofloxacina Viatris is manufactured under EU regulations and complies with international quality standards.

GNH USA supplies Ofloxacina Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacina Viatris is a fluoroquinolone antibiotic used to manage infections caused by susceptible bacteria. - Urinary tract infection: eradicates common uropathogens and resolves symptoms. - Acute bacterial sinusitis: reduces bacterial load and improves sinus drainage. - Skin and soft‑tissue infection: treats cellulitis and wound infections caused by Gram‑negative and Gram‑positive organisms. - Chronic bacterial prostatitis: penetrates prostatic tissue to eliminate infection. - Uncomplicated gonorrhea: provides rapid bacterial clearance in genital infections.

Adverse reactions may occur with Ofloxacina Viatris and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Rash: mild skin erythema. - Photosensitivity: increased sun sensitivity.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur during or after therapy. - QT interval prolongation: risk of cardiac arrhythmia. - Central nervous system effects: seizures or severe confusion. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile colitis: severe intestinal infection. - Hepatotoxicity: elevated liver enzymes or jaundice.

Before prescribing Ofloxacina Viatris, clinicians should consider patient‑specific factors and safety measures. - Tendon health: avoid use in patients with recent tendon injury or corticosteroid therapy. - Cardiac risk: assess QT interval in patients with known arrhythmias. - Renal function: adjust use in severe renal impairment. - Pregnancy and lactation: contraindicated unless benefits outweigh risks. - Drug hypersensitivity: review history of fluoroquinolone allergy. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture and direct sunlight.

Ofloxacina Viatris may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of ofloxacin. - NSAIDs (e.g., ibuprofen, diclofenac): increase risk of central nervous system stimulation. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Corticosteroids: heightened risk of tendon rupture. - Theophylline: possible increase in plasma concentrations. - Cyclosporine: may raise cyclosporine levels, necessitating dose adjustment.